Acquisition History / Curium / Lantheus Holdings
Curium Acquires Lantheus Holdings
Announced August 3, 2026 — $8B
What happened
Lantheus is a US-listed radiopharmaceutical company. Luxembourg-parented, Paris-headquartered nuclear medicine group Curium agreed to acquire it in a transaction worth up to US$8B.
- Acquirer
- Curium
- Target
- Lantheus Holdings
- Announced
- August 3, 2026
- Price
- $8B
- Industry
- Radiopharmaceuticals / nuclear medicine
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Curium acquire Lantheus Holdings?
Curium acquired Lantheus Holdings on August 3, 2026. This was Curium's 1st publicly tracked acquisition out of 1 we have on record.
How much did Curium pay for Lantheus Holdings?
Curium paid $8B for Lantheus Holdings.
What does Lantheus Holdings do?
Lantheus is a US-listed radiopharmaceutical company. Luxembourg-parented, Paris-headquartered nuclear medicine group Curium agreed to acquire it in a transaction worth up to US$8B.
What other Radiopharmaceuticals / nuclear medicine companies has Curium acquired?
Lantheus Holdings is Curium's only publicly tracked acquisition in Radiopharmaceuticals / nuclear medicine so far.